Alaska Administrative Code › Title 12 - Professional Regulations › Part 1 - Boards and Commissions Subject to Centralized Licensing › Chapter 52 - Board of Pharmacy › Article 9 - Controlled Substance Prescription Database › 12 AAC 52.865 - Reporting and reviewing PDMP information

Current through May 31, 2024
(a) Unless excused
				  from reporting under
				  AS
				  17.30.200(t), a
				  pharmacist-in-charge must submit information on behalf of the employing
				  pharmacy required under
				  AS
				  17.30.200(b) and other
				  information required by the American Society of Automation in Pharmacy (ASAP),
				  as specified in the Appriss Health, PMP AWARxE
Data Submission Guide
				  for Dispensers, Alaska Prescription Drug Monitoring Program
, Version
				  2.2, April 2021, adopted by reference. If the pharmacist-in-charge is not
				  present, a pharmacist or third-party vendor may report on behalf of the
				  pharmacy. A practitioner, practitioner's delegate, or third-party vendor may
				  also report on behalf of the practitioner.
(b) Unless excused from reporting under
				  AS
				  17.30.200(t), a pharmacist
				  or practitioner required to submit information under
				  AS
				  17.30.200(b) must submit the
				  information to the PDMP daily. Information regarding a schedule II, III, or IV
				  controlled substance prescribed by a veterinarian and dispensed by a pharmacist
				  must be submitted by the pharmacist. Nothing affects the inapplicability of
				  this section to veterinarians under
				  AS
				  17.30.200(u).
(c) If the pharmacist or practitioner did not
				  dispense any Schedule II, III, or IV controlled substances on the previous day,
				  the pharmacist or practitioner must submit a zero report.
(d) The time computation under
				  12 AAC 02.920(b)
				  applies to a submission of information under
				  AS
				  17.30.200(b) and this
				  section.
(e) For the purposes of
				  AS
				  17.30.200(b)(1), "other
				  appropriate identifier" and for the purposes of17.30.200(b)(8), "other
				  appropriate identifying information" mean the state-issued license number of
				  the prescribing practitioner and state-issued license number of the dispensing
				  pharmacist or practitioner.
(f) Not
				  later than 72 hours after discovering an error in information submitted under
				  AS
				  17.30.200(b), a pharmacist
				  or practitioner required to submit the information under
				  AS
				  17.30.200(b) must notify the
				  PDMP administrator. The time computation under
				  12 AAC 02.920(b)
				  applies to a submission of information correcting an error in information
				  submitted under
				  AS
				  17.30.200(b).
(g) Unless excused from reporting under
				  AS
				  17.30.200(t), or a waiver is
				  granted under
				  12 AAC 52.870, a pharmacist or
				  practitioner required to submit information under
				  AS
				  17.30.200(b) must submit the
				  information to the PDMP electronically through the website provided by the
				  board.
(h) Unless excused from
				  reviewing the PDMP under
				  AS
				  17.30.200(k)(4)(A) - (B), a
				  practitioner, but not a pharmacist, must review the information in the PDMP to
				  check a patient's prescription records before dispensing, prescribing, or
				  administering a schedule II or III controlled substance under federal
				  law.
As of Register 233 (April 2020), the regulations attorney
						made a technical revision under
						AS
						44.62.125(b)(6), to
						12 AAC 52.865(b).
In 2018 the revisor of statutes, acting under
						AS
						01.05.031, rearranged the subsections in
						AS
						17.30.200. As a result, the subsection
						formerly designated as
						AS
						17.30.200(o) is now
						designated as
						AS
						17.30.200(n). As of Register
						237 (April 2021), the regulations attorney made a conforming technical revision
						under AS
						44.62.125(b)(6), to
						12 AAC 44.445(d),
						so that the cross-reference now cites
						AS
						17.30.200(n), formerly
						designated
						AS
						17.30.200(o).
The regulations attorney made a technical revision under
						AS
						44.62.125. to set out a cross-reference to
						AS
						17.30.200(u). Sec. 5, ch.
						14, SLA 2023 originally enacted the statutory subsection as
						AS
						17.30.200(v). but the
						revisor of statutes, acting under
						AS
						01.05.031, is expected upon final
						codification to assign that statutory material to
						AS
						17.30.200(u), and assign
						AS
						17.30.200(v) to the current
						section-specific definitions.
Authority:
AS
						08.80.005
AS 08.80.030
AS
						17.30.200